alexa
 
Home News Piramal acquires portfolio of drugs from Mallinckrodt LLC

Read more interesting news from around the globe with Wealth Doctor App

Google Play
 
Piramal acquires portfolio of drugs from Mallinckrodt LLC

Piramal acquires portfolio of drugs from Mallinckrodt LLC

Monday, March 20, 2017, 9:56 AM

Mumbai based, Piramal Enterprises Limited’s UK subsidiary, Critical Care has acquired a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC. The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently under development. The acquisition was for a cash consideration of USD 171 million.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!